Biohaven Ltd. (BHVN) News & Overview - Discounting Cash Flows
BHVN
Biohaven Ltd.
BHVN (NYSE)

BHVN's Business Model

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Sector & Industry Healthcare / Biotechnology
Website https://www.biohaven.com
CEO (Chief Executive Officer) Vladimir Coric
Number of Employees
IPO date September 23, 2022

BHVN Latest News

Contact
CountryUS
Address215 Church Street
CityNew Haven
StateCT
Phone203 404 0410
Zip Code06510
Other Identifiers
CIK0001935979
ISINVGG1110E1079
CUSIPG11196105
Open13.9
Previous Close13.79
Volume1.05 Mil.
Average Volume2.17 Mil.
Day’s Range13.85 – 14.18
52 Week Range13.745-55.7
MA (50)16.8028
MA (200)33.4526
Market Cap1.42 Bil.
Shares Out.102.1 Mil.
Earnings DateAug 05, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for BHVN

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us